Evidence map›Paper›PMID 42558355›Full record

ReviewFrontiers in cellular and infection microbiology2026

The cycle of infectious fever - how it affects bacterial infections.

Kinga Kramarczyk, Piotr Schmidt, Karina Krasna, Weronika Jasińska, Anna Jarzab

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kinga KramarczykDepartment of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Wroclaw, Poland.
Piotr SchmidtDepartment of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Wroclaw, Poland.
Karina KrasnaDepartment of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Wroclaw, Poland.
Weronika JasińskaDepartment of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Wroclaw, Poland.
Anna JarzabDepartment of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Wroclaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fever is one of the human body's most effective strategies in fighting infections. However, its precise role in eliminating pathogens, specifically the influence of heat on the bacterial cells on the mechanistic level under febrile temperatures has never been fully delineated. The concept of fever, as the immune system's first line of defense against pathogens involves two main components: the inflammatory response and the heat, which stimulates the host's immune cells and affects pathogens. This article summarizes independent findings, grouping the development of fever into a circular model, starting with pathogen invasion and the release of bacteria's exogenous pyrogens, continuing through the host immune response, and debating on the impact of fever on numerous human pathogens. This model focuses broadly on processes occurring within bacteria, particularly pathogen adaptation and the detrimental effect of heat released during fever on pathogen death. We also discussed the impact of commonly used antipyretics, such as acetaminophen, ibuprofen, and aspirin, on the overall outcome of infection and provided a framework within which new concepts and findings in this field can be developed.

Indexed as

Bacterial InfectionsFeverHost-Pathogen InteractionsAnimalsAntipyreticsBacteriaHot TemperatureHumansPyrogensAntipyreticsPyrogensbacteriafeverimmune responseinfectionpyrogens

Identifiers

PMID42558355
PMCPMC13437493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.